INVESTOR CENTRE

Dear Investors,

Welcome to Myopharm, a clinical stage company with a strong clinical pipeline in preventing metabolic diseases. Myopharm have expert management coupled with an efficient business model and an ambitious roadmap. R&D and manufacturing, are the core of our development. Myopharm believe in long and sustainable partnerships. With the sharp rise in Prediabetes and Type 2 diabetes globally, We believe that your health cannot afford to wait.

Share Registry

Corporate Governance


Shareholder Updates

17/03/2025

Dr George Tachas and Advait Padhye joins Myopharm’s Scientific Team

06/02/2025

Myopharm strengthens clinical development team with appointment of Tamara Miller